I chose to work with USDM Life Sciences to become a part of the team that supports a holistic view of adoption and implementation of UDI from the manufacturer to the distributor to the providers with patient safety as the focus.
SANTA BARBARA, CALIFORNIA (PRWEB) August 06, 2015
At USDM Life Sciences, Sargent will focus on processes that will improve patient safety within healthcare organizations, such as assessment of current processes, completion of gap analyses to determine processes, technology and people required to implement bar code scanning of the Unique Device Identifier (UDI) on medical devices from the receiving dock through to the electronic health record.
“Jean is the ideal person to help improve the healthcare supply chain by providing leadership and resources to support healthcare providers to not only improve patient safety but cut operational costs as well,” said Kevin Brown, Managing Partner at USDM Life Sciences.
As a recognized thought leader in healthcare supply chain, Sargent’s passion has been adoption and implementation of standards which demonstrates product traceability from manufacture through to patient use. Sargent has implemented bar code scanning of packages and understands the intricacies and importance of end to end traceability in supporting patient safety. Sargent became fully involved with the standards movement during her AHRMM presidency in 2007. Sargent has presented and written on adoption and implementation of standards on many occasions.
“I chose to work with USDM Life Sciences to become a part of the team that supports a holistic view of adoption and implementation of UDI from the manufacturer to the distributor to the providers with patient safety as the focus,” said Sargent. “USDM Life Sciences’ long standing collaboration with the manufacturer’s will be taken to the next level to include distributors and providers.”
With over 25 years of leadership in supply chain management, Sargent will invoke her experiences to assist in implementation of people, processes, and technology to bridge traceability of the UDI which in the end supports Office of the National Coordinator (ONC) and Centers for Medicare & Medicaid (CMS) Meaningful Use Rule. Product recalls are a significant issue which compromises patient safety. Adoption of UDI will enhance the traceability of adverse event reporting, medical errors and product recalls.
About USDM Life Sciences:
USDM Life Sciences has more than 15 years of experience supplying clients in the healthcare and life science industries with compliance services while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. For more information, please visit http://www.usdm.com.